Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-005496
Filing Date
2025-02-25
Accepted
2025-02-25 16:28:11
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 form4a-02252025_090206.html 4/A  
1 form4a-02252025_090206.xml 4/A 4674
  Complete submission text file 0001415889-25-005496.txt   6051
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address
Morgen Eric (Reporting) CIK: 0002036289 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-42279 | Film No.: 25663755